Home > Browse Research > Life Sciences > Biotechnology > Biomarkers

Biomarkers: market research reports

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers can be valuable tools in clinical diagnostics as well as in therapeutic discovery and development. They can be used to predict response to therapy or risk of side effects for personalized medicine applications.

Additional types include predisposition, screening, diagnostic, prognostic, toxicity, pharmacodynamic, and other biomarkers.

The existence of living organisms or biological processes, a particular disease state, or a fragment of DNA sequence can indicate biomarkers. Locations of a particular molecule (cellular or subcellular, tissue or organ locations) can also be a biomarker.

Biomarkers ideal for diagnosis should have great sensitivity, specificity, and accuracy in reflecting total disease burden. A tumor marker should also be prognostic of outcome and predictive of tumor recurrence and effectiveness of anti-cancer treatments.

Biomarkers for screening purposes must be highly specific, minimizing false positive and negative results. The biomarker must be able to clearly reflect the early stage of disease and it must be easily detected without complicated medical procedures. The disease markers released to serum and urine are good targets for application of early screening. The method for screening should be cost effective. Biomarkers are commonly detected through blood, urine, other body fluids, and tissue samples.

Biomarkers play a major role in medicinal biology. Biomarkers bring the future things in our hand by helping in early diagnosis, disease prevention, drug target identification, drug response etc. Several disease-based biomarkers had been identified for many diseases such as serum LDL for cholesterol, blood pressure, P53 gene and MMPs for cancer. Gene based biomarkers are found to be effective and acceptable markers in the present scientific world.

Biomarkers market research reports and industry analysis

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives 5/8/2013 \| published by: Kalorama Information ... selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition. This report, authored by Kalorama Diagnostic Analyst Shara ... \| read more...	$4,500.00
Personalized Medicine Market Analysis 5/1/2013 \| published by: RNCOS ... per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing ... \| read more...	$1,200.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts 4/30/2013 \| published by: GlobalData ... market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and ... \| read more...	$4,450.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4/30/2013 \| published by: GlobalData ... of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, ... \| read more...	$4,450.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts 4/30/2013 \| published by: GlobalData ... this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme ... \| read more...	$4,450.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts 4/30/2013 \| published by: GlobalData ... diagnostics market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme ... \| read more...	$4,450.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players 4/30/2013 \| published by: GlobalData ... of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency ... \| read more...	$3,500.00
Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players 4/1/2013 \| published by: GlobalData ... of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency ... \| read more...	$3,500.00
Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts 4/1/2013 \| published by: GlobalData ... market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and ... \| read more...	$4,450.00
Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts 4/1/2013 \| published by: GlobalData ... diagnostics market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme ... \| read more...	$4,450.00
Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts 4/1/2013 \| published by: GlobalData ... this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme ... \| read more...	$4,450.00
Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4/1/2013 \| published by: GlobalData ... of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, ... \| read more...	$4,450.00
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets 3/1/2013 \| published by: BCC Research ... be used to diagnose or predict disease, monitor disease progression, and predict treatment response. Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017. ... \| read more...	$5,450.00
Biomarker Partnering Terms and Agreements 3/1/2013 \| published by: Current Partnering ... agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements ... \| read more...	$2,795.00
Conference Documentation: Biomarkers Summit 1/16/2013 \| published by: SMI Publishing, Ltd ... early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumorsInteractive panel discussion focusing on current developments in personalised medicine ... \| read more...	$788.78
Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017 1/14/2013 \| published by: MarketsandMarkets ... science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a ... \| read more...	$4,650.00
Global Cancer Biomarkers Market 2012-2016 1/11/2013 \| published by: Infiniti Research Limited ... cancer. The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market. ... \| read more...	$2,000.00
Pharma Clinical Trial Services: World Market 2013-2023 1/1/2013 \| published by: Visiongain ... It explains trends, opportunities and commercial prospects. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in clinical trial outsourcing, ... \| read more...	$2,497.00
Therapies and Biomarkers for Inflammatory Bowel Disease 1/1/2013 \| published by: BCC Research ... 2012, and projections of compound annual growth rates (CAGRs) through 2017 Discussion of the types of IBD, including Crohn's disease, ulcerative colitis, and other (ischemic, diversionary, Bechet's) Examination of the types of IBD diagnostics, such ... \| read more...	$5,450.00
Orphan Drugs: Market Environment Products and Companies 12/17/2012 \| published by: Espicom Healthcare Intelligence ... and high unmet medical needs. In addition, the fast track approval system allows companies to enter the market faster and more cost-effectively with the potential to extend indications. Significant unmet clinical need While orphan diseases ... \| read more...	$1,390.00
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes 11/9/2012 \| published by: GBI Research ... Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and analysis on the major trends and issues affecting biomarkers in the drug discovery process. The report describes the history of biomarkers and their role in fulfilling ... \| read more...	$3,500.00
Biomarker Partnering Terms & Agreements 10/1/2012 \| published by: Current Partnering ... agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements ... \| read more...	$2,695.00
Future Horizons in the European Cancer Diagnostics Market - France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country 9/11/2012 \| published by: Venture Planning Group ... diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers ... \| read more...	$18,500.00
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market 9/11/2012 \| published by: GBI Research ... Development Costs and Time to Market”, presents various tools and strategies which can accelerate a drug to the market. In this report, GBI Research has studied various hurdles at different stages of drug development that ... \| read more...	$3,500.00
Future Horizons in the Global Tumor Marker Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country 8/30/2012 \| published by: Venture Planning Group ... test volume and sales forecasts by country. Contains 11 pages and 3 tables Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of ... \| read more...	$2,450.00

< prev 1 2 3 4 5 6 next >